Page 7 - Brook Baker News Today

After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.

HARARE, Zimbabwe -- After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwes capital in search of a fre...

HARARE, Zimbabwe (AP) — After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.

The sudden emergence of the Omicron variant of SARS-CoV-2 is adding pressure on vaccine makers to ensure their shots are available worldwide.

U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.

As covid-19 puts new strains on parents, the pandemic is making clear what many experts had long warned even in more stable times: The absence of reliable and affordable child care limits which jobs people can accept, makes it harder to climb the corporate ladder and ultimately restricts the ability of the broader economy to grow.

As covid-19 puts new strains on parents, the pandemic is making clear what many experts had long warned even in more stable times: The absence of reliable and affordable child care limits which jobs people can accept, makes it harder to climb the corporate ladder and ultimately restricts the ability of the broader economy to grow.

Daryl Maguire is scheduled to be questioned by NSW’s anti-corruption watchdog on Thursday; Gladys Berejiklian will follow on Friday. Follow updates here.

The Bill & Melinda Gates Foundation is committing up to $120 million to accelerate production of generic versions of Merck's Covid-19 drug.

Wealthy countries have bought up most of the available vaccine doses for booster shots but still have far more than they need